achieved its primary endpoint in participants with cervical high-grade squamous intraepithelial lesions (HSIL). HSIL are precancerous lesions linked to human papillomavirus (HPV) that can lead to ...
The incidence of cervical intraepithelial neoplasia (CIN ... A large majority of high-grade lesions in the female genital tract emerge as monoclonal cell populations derived from the cervical ...
Focusing development efforts for cancer-preventive drugs on precancerous lesions (that is,intraepithelial neoplasia (IEN)) can reduce costs and accelerate the emergence of new cancer-preventive drugs.
Researchers at the University of Pittsburgh have identified a novel trigger for a deadly form of ovarian cancer: a subset of ...
Hosted on MSN1mon
A therapeutic HPV vaccine could eliminate precancerous cervical lesions, clinical trial suggestsLesion size was significantly reduced in all ... a therapeutic vaccine for patients with HPV16-positive high-grade cervical intraepithelial neoplasia: a Phase II trial, Clinical Cancer Research ...
The Anal Cancer/High-grade squamous intraepithelial lesions Outcomes Research (ANCHOR) trial demonstrated that treating precancerous anal HSIL reduces the incidence of anal cancer by 57% in people ...
Abstract Thinking and Statins With Immune Checkpoint Inhibitors: Enough to Change Clinical Practice? Using an index designed and validated for use in ANCHOR, HRQoL was assessed before random ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback